Login / Signup

In vivo assessment of the drug interaction between sorafenib and paracetamol in rats.

Agnieszka KarbownikKatarzyna SobańskaTomasz GrabowskiJoanna Stanisławiak-RudowiczAnna WolcEdmund GrześkowiakEdyta Szałek
Published in: Cancer chemotherapy and pharmacology (2020)
A greater knowledge of DDI between sorafenib and paracetamol may help adjust dose properly and avoid toxicity effects in individual patients.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • ejection fraction
  • newly diagnosed
  • healthcare
  • peritoneal dialysis
  • oxidative stress
  • prognostic factors